#GoASCO20 OR #ASCO20 until:2020-05-31, Twitter, 6/2/2020 6:27:07 AM, 228662


FAQ | Problem?

#GoASCO20 OR #ASCO20 until:2020-05-31 Twitter NodeXL SNA Map and Report for Monday, 01 June 2020 at
#GoASCO20 OR #ASCO20 until:2020-05-31 Twitter NodeXL SNA Map and Report for Monday, 01 June 2020 at
From:
scotpublichealth
Uploaded on:
June 02, 2020
Short Description:
#GoASCO20 OR #ASCO20 until:2020-05-31 via NodeXL https://bit.ly/2XRiNS7
@asco
@oncoalert
@tmprowell
@marklewismd
@ega0709
@msdlatam
@conquercancerfd
@davidfajgenbaum
@crisbergerot
@stephenvliu

Top hashtags:
#asco20
#lcsm
#bcsm
#covid19
#oncoalert
#cancer
#ccc19

Description:
Description
The graph represents a network of 5,567 Twitter users whose recent tweets contained "#GoASCO20 OR #ASCO20 until:2020-05-31", or who were replied to or mentioned in those tweets, taken from a data set limited to a maximum of 18,000 tweets. The network was obtained from Twitter on Monday, 01 June 2020 at 21:37 UTC.

The tweets in the network were tweeted over the 1-day, 6-hour, 19-minute period from Friday, 29 May 2020 at 17:40 UTC to Saturday, 30 May 2020 at 23:59 UTC.

Additional tweets that were mentioned in this data set were also collected from prior time periods. These tweets may expand the complete time period of the data.

There is an edge for each "replies-to" relationship in a tweet, an edge for each "mentions" relationship in a tweet, and a self-loop edge for each tweet that is not a "replies-to" or "mentions".

The graph is directed.

The graph's vertices were grouped by cluster using the Clauset-Newman-Moore cluster algorithm.

The graph was laid out using the Harel-Koren Fast Multiscale layout algorithm.


Author Description


Overall Graph Metrics
Vertices : 5567
Unique Edges : 23663
Edges With Duplicates : 26674
Total Edges : 50337
Self-Loops : 2672
Reciprocated Vertex Pair Ratio : 0.0706708663697911
Reciprocated Edge Ratio : 0.132012308524668
Connected Components : 178
Single-Vertex Connected Components : 106
Maximum Vertices in a Connected Component : 5253
Maximum Edges in a Connected Component : 49908
Maximum Geodesic Distance (Diameter) : 10
Average Geodesic Distance : 3.550403
Graph Density : 0.000954401163212119
Modularity : 0.297789
NodeXL Version : 1.0.1.433
Graph Gallery URL : https://nodexlgraphgallery.org/Pages/Graph.aspx?graphID=228661
Data Import : The graph represents a network of 5,567 Twitter users whose recent tweets contained "#GoASCO20 OR #ASCO20 until:2020-05-31", or who were replied to or mentioned in those tweets, taken from a data set limited to a maximum of 18,000 tweets. The network was obtained from Twitter on Monday, 01 June 2020 at 21:37 UTC.

The tweets in the network were tweeted over the 1-day, 6-hour, 19-minute period from Friday, 29 May 2020 at 17:40 UTC to Saturday, 30 May 2020 at 23:59 UTC.

Additional tweets that were mentioned in this data set were also collected from prior time periods. These tweets may expand the complete time period of the data.

There is an edge for each "replies-to" relationship in a tweet, an edge for each "mentions" relationship in a tweet, and a self-loop edge for each tweet that is not a "replies-to" or "mentions".

Layout Algorithm : The graph was laid out using the Harel-Koren Fast Multiscale layout algorithm.
Graph Source : TwitterSearch
Graph Term : #GoASCO20 OR #ASCO20 until:2020-05-31
Groups : The graph's vertices were grouped by cluster using the Clauset-Newman-Moore cluster algorithm.
Edge Color : Edge Weight
Edge Width : Edge Weight
Edge Alpha : Edge Weight
Vertex Radius : Followers
Vertex Alpha : Followers

Top Influencers: Top 10 Vertices, Ranked by Betweenness Centrality
Top URLs
Top URLs in Tweet in Entire Graph:
[53] https://ccc19.org/
[31] http://www.CONQUER.ORG/Together?utm_content=WeCanVideo&utm_medium=social&utm_campaign=COVIDImpactsCancer&utm_source=twitter
[28] https://www.mdanderson.org/for-physicians/connect-with-us/md-anderson-at-asco.html
[25] https://tactic-ct.fr
[16] https://www.onclive.com/conference-coverage/asco-2020/alpelisib-impresses-in-pi3kca-breast-cancer-after-progression-on-cdk-inhibition?fbclid=IwAR3HDmxii0DmIOOspG5UA_JJfeY3iWB2cpab05_qT_HJ9ZWLdx48KSx2sV0
[16] https://meetinglibrary.asco.org/results;page=0?filters=JTVCJTdCJTIyZmllbGQlMjIlM0ElMjJNZWRpYVR5cGVzJTIyJTJDJTIydmFsdWUlMjIlM0ElMjJBYnN0cmFjdHMlMjIlMkMlMjJxdWVyeVZhbHVlJTIyJTNBJTIyQWJzdHJhY3RzJTIyJTJDJTIyY2hpbGRyZW4lMjIlM0ElNUIlNUQlN0QlNUQ%3D&meetingView=2020%20ASCO%20Virtual%20Scientific%20Program
[15] https://meetinglibrary.asco.org/browse-meetings/2020%20ASCO%20Virtual%20Scientific%20Program
[14] https://fal.cn/38jSH
[14] https://meetinglibrary.asco.org/record/186999/abstract
[12] https://twitter.com/ASCOPres/status/1265727063144697858

Top URLs in Tweet in G1:
[28] https://www.mdanderson.org/for-physicians/connect-with-us/md-anderson-at-asco.html
[19] https://tactic-ct.fr
[13] https://meetinglibrary.asco.org/record/186999/abstract
[11] https://meetinglibrary.asco.org/browse-meetings/2020%20ASCO%20Virtual%20Scientific%20Program
[5] https://twitter.com/n8pennell/status/1266437139769810946
[5] https://twitter.com/pashtoonkasi/status/1266331280326766592
[5] https://fal.cn/38jSH
[5] https://www.cancer.gov/news-events/events/conferences/asco-2020#watch-dr-sharpless-speak-about-cancer-care-in-the-time-of-covid
[5] https://meetinglibrary.asco.org/record/187064/abstract
[5] https://meetinglibrary.asco.org/results;page=0?filters=JTVCJTdCJTIyZmllbGQlMjIlM0ElMjJNZWRpYVR5cGVzJTIyJTJDJTIydmFsdWUlMjIlM0ElMjJBYnN0cmFjdHMlMjIlMkMlMjJxdWVyeVZhbHVlJTIyJTNBJTIyQWJzdHJhY3RzJTIyJTJDJTIyY2hpbGRyZW4lMjIlM0ElNUIlNUQlN0QlNUQ%3D&meetingView=2020%20ASCO%20Virtual%20Scientific%20Program

Top URLs in Tweet in G2:
[23] http://www.CONQUER.ORG/Together?utm_content=WeCanVideo&utm_medium=social&utm_campaign=COVIDImpactsCancer&utm_source=twitter
[11] https://www.onclive.com/conference-coverage/asco-2020/alpelisib-impresses-in-pi3kca-breast-cancer-after-progression-on-cdk-inhibition?fbclid=IwAR3HDmxii0DmIOOspG5UA_JJfeY3iWB2cpab05_qT_HJ9ZWLdx48KSx2sV0
[8] https://twitter.com/ASCOPres/status/1265727063144697858
[7] https://pharmaphorum.com/oncology/asco-2020-virtual-meeting-day-2/
[6] https://twitter.com/ascopres/status/1266726825448923138
[6] https://www.conquer.org/news/conquer-cancer-grants-more-8-million-cancer-research?utm_content=WeCanVideo&utm_medium=social&utm_campaign=COVIDImpactsCancer&utm_source=twitter
[5] https://twitter.com/tmprowell/status/1266791439385706497
[5] https://meetinglibrary.asco.org/user/login?destination=/node/69066
[5] https://twitter.com/davidfajgenbaum/status/1266764869916860416
[5] https://twitter.com/tigerlilycares/status/1266444135281709056

Top URLs in Tweet in G3:
[53] https://ccc19.org/
[9] https://meetinglibrary.asco.org/results;page=0?filters=JTVCJTdCJTIyZmllbGQlMjIlM0ElMjJNZWRpYVR5cGVzJTIyJTJDJTIydmFsdWUlMjIlM0ElMjJBYnN0cmFjdHMlMjIlMkMlMjJxdWVyeVZhbHVlJTIyJTNBJTIyQWJzdHJhY3RzJTIyJTJDJTIyY2hpbGRyZW4lMjIlM0ElNUIlNUQlN0QlNUQ%3D&meetingView=2020%20ASCO%20Virtual%20Scientific%20Program
[7] https://www.esmo.org/newsroom/esmo-society-news/coronavirus-update-from-esmo
[6] https://meetinglibrary.asco.org/record/188303/video
[6] https://fal.cn/38jSH
[6] https://meetinglibrary.asco.org/record/191968/abstract
[5] http://www.CONQUER.ORG/Together?utm_content=WeCanVideo&utm_medium=social&utm_campaign=COVIDImpactsCancer&utm_source=twitter
[5] https://meetinglibrary.asco.org/record/186872/abstract
[5] https://www.imdconline.com/
[5] https://secure.jbs.elsevierhealth.com/action/getSharedSiteSession?redirect=https%3A%2F%2Fwww.thelancet.com%2Fjournals%2Flancet%2Farticle%2FPIIS0140-6736%2820%2931187-9%2Ffulltext&rc=0

Top URLs in Tweet in G4:
[4] https://meetinglibrary.asco.org/record/189385/poster
[3] https://twitter.com/melisawongmd/status/1266432244127690752
[2] https://www.medscape.com/viewarticle/930586?src=soc_tw_200518_mscpedt_news_onc_asco20&faf=1
[2] https://www.medscape.com/viewarticle/931391?src=soc_tw_200530_mscpedt_news_onc_nsclc&faf=1
[2] https://www.medscape.com/viewarticle/930881?src=soc_tw_200529_mscpedt_news_onc_asco20&faf=1
[1] https://twitter.com/GeriSoc/status/1266397265184411649
[1] https://twitter.com/nazlidizman/status/1265416336227790848
[1] https://meetinglibrary.asco.org/record/190520/abstract
[1] https://twitter.com/nicolobattisti/status/1266787456122306560
[1] https://dailynews.ascopubs.org/do/10.1200/ADN.20.200169/full/?cookieSet=1

Top URLs in Tweet in G5:
[7] https://www.libtayo360xp.com/?utm_source=TwitterRegeneron&utm_medium=Bitly1&utm_campaign=ASCO2020&utm_content=Outlets
[7] https://www.libtayo360xp.com/?utm_source=TwitterRegeneron&utm_medium=Bitly1&utm_campaign=ASCO2020&utm_content=Institutions
[5] https://www.youtube.com/watch?v=wqi7Yvv0cy8&t=50s

[4] https://www.libtayo360xp.com/?utm_source=TwitterRegeneron&utm_medium=Bitly1&utm_campaign=ASCO2020&utm_content=Keywords
[3] https://www.amgenoncology.com/
[2] https://www.amgenoncology.com/targets/CD33.html
[1] http://r.socialstudio.radian6.com/d62ec31b-3232-4964-90d6-3c747c60c0f4
[1] http://r.socialstudio.radian6.com/3fdc6530-0bd3-4d50-b95f-cb38907657f7
[1] https://cosmictrials.com/cosmic-311.html
[1] https://meetings.asco.org/am/virtual-program

Top URLs in Tweet in G6:
[2] https://meetinglibrary.asco.org/record/187764/abstract
[1] https://meetinglibrary.asco.org/record/185133/abstract
[1] https://meetinglibrary.asco.org/record/185644/abstract
[1] https://meetinglibrary.asco.org/record/186826/abstract
[1] https://meetinglibrary.asco.org/record/185343/abstract
[1] https://news.weill.cornell.edu/news/2020/05/enzalutamide-prolongs-lives-of-patients-with-nonmetastatic-castration-resistant?utm_campaign=.edu+site&utm_content=1590693383&utm_medium=social&utm_source=twitter
[1] https://meetinglibrary.asco.org/record/186009/abstract
[1] https://meetinglibrary.asco.org/record/191811/abstract
[1] https://meetinglibrary.asco.org/record/190759/video
[1] https://meetinglibrary.asco.org/

Top URLs in Tweet in G7:
[6] https://rwe.flatiron.com/asco
[4] http://www.unicancer.fr/actualites/groupe/reseau-unicancer-l%E2%80%99asco-2020?utm_source=hootsuite&utm_medium=linkedin&utm_term=&utm_content=7a74b202-41e9-4733-a64f-926e263cedc9&utm_campaign=%23UnicancerASCO20
[4] https://www.mdedge.com/hematology-oncology/conferences/asco-american-society-clinical-oncology
[2] https://www.comprehensivegenomicprofiling.com/#OurPresenceAtAsco
[2] https://www.mdedge.com/hematology-oncology/article/222909/lung-cancer/adjuvant-osimertinib-extends-dfs-localized-nsclc
[2] https://meetinglibrary.asco.org/record/185883/abstract
[2] https://www.mdedge.com/hematology-oncology/article/223029/breast-cancer/pembrolizumab-plus-chemo-shows-benefits-pd-l1-rich
[2] http://www.icl-lorraine.fr/images/PDF/com_dons/CP-Prodige_23-ASCO_presse_region_26052020.pdf
[2] https://meetinglibrary.asco.org/record/184739/poster
[1] https://www.gene.com/stories/widening-the-circle?topic=cancer-immunotherapy&utm_source=twitter&utm_medium=paid&utm_content=article&utm_campaign=ONC_EXEC_ARTI_ASCO_LI&utm_term=CR&sf122593005=1

Top URLs in Tweet in G8:
[7] https://www.delveinsight.com/asco-conference
[6] https://www.calquencehcp.com/
[3] https://www.linkedin.com/slink?code=gsKKvpv
[2] https://www.cancerresearch.org/patients/clinical-trials
[2] https://www.qmul.ac.uk/media/news/2020/smd/immunotherapy-improves-survival-in-patients-with-advanced-bladder-cancer.html
[2] https://www.linkedin.com/slink?code=gbttNbe
[1] https://www.tempus.com/tempus-launches-covid-19-specific-clinical-and-research-initiatives-for-oncology/?utm_medium=social&utm_source=twitter&utm_campaign=asco
[1] https://www.tempus.com/tempus-time-trial-program-reaches-critical-scale-and-operational-milestones/?utm_medium=social&utm_source=twitter&utm_campaign=asco
[1] https://meetinglibrary.asco.org/record/186105/abstract/
[1] https://www.cancerresearch.org/blog/may-2020/investigating-innate-immune-receptor-nlrp6

Top URLs in Tweet in G9:
[4] https://www.saluteh24.com/il_weblog_di_antonio/2020/05/tumori-con-fusione-ntrk-71-di-risposta-globale-nei-pazienti-con-metastasi-cerebrali-asco20.html
[4] https://www.saluteh24.com/il_weblog_di_antonio/2020/05/melanoma-nuovi-dati-per-pazienti-ad-alto-rischio-di-recidiva-dopo-chirurgia-asco20.html
[3] https://www.asco.org:443/
[2] https://www.takeda.com/newsroom/newsreleases/2020/takeda-announces-compelling-data-from-the-phase-2-trial-of-pevonedistat-plus-azacitidine-in-patients-with-higher-risk-mds/
[2] https://www.fiercebiotech.com/research/asco-allogene-reports-63-response-rate-early-trial-off-shelf-car-t-lymphoma
[2] https://meetinglibrary.asco.org/results?meetingView=2020%20ASCO%20Virtual%20Scientific%20Program
[2] http://MedicalResearch.com
[1] https://dailynews.ascopubs.org/do/10.5555/ADN.20.200106/full/?cid=DM5191&bid=45922853&cookieSet=1
[1] https://meetinglibrary.asco.org/browse-meetings/2020%20ASCO%20Virtual%20Scientific%20Program
[1] https://meetinglibrary.asco.org/record/191964/video

Top Domains
Top Domains in Tweet in Entire Graph:
[1344] twitter.com
[661] asco.org
[84] onclive.com
[58] ccc19.org
[55] ascopubs.org
[54] conquer.org
[45] 1stoncology.com
[42] mdanderson.org
[31] youtube.com
[30] fal.cn

Top Domains in Tweet in G1:
[366] twitter.com
[237] asco.org
[60] onclive.com
[41] mdanderson.org
[27] targetedonc.com
[19] tactic-ct.fr
[16] ascopost.com
[13] obroncology.com
[12] medicinematters.com
[8] youtube.com

Top Domains in Tweet in G2:
[563] twitter.com
[141] asco.org
[36] conquer.org
[16] ascopubs.org
[15] onclive.com
[11] instagram.com
[11] fal.cn
[10] jamanetwork.com
[10] youtube.com
[9] pharmaphorum.com

Top Domains in Tweet in G3:
[286] twitter.com
[142] asco.org
[58] ccc19.org
[22] ascopubs.org
[14] nejm.org
[11] conquer.org
[11] seattlecca.org
[10] elsevierhealth.com
[10] fal.cn
[8] esmo.org

Top Domains in Tweet in G4:
[17] twitter.com
[8] asco.org
[8] medscape.com
[2] ascopubs.org
[2] uab.edu
[1] bit.ly
[1] youtube.com
[1] lww.com
[1] tactic-ct.fr

Top Domains in Tweet in G5:
[19] libtayo360xp.com
[5] youtube.com
[5] amgenoncology.com
[3] asco.org
[2] radian6.com
[2] findkrasg12c.com
[2] roche.com
[2] gsk.com
[2] nature.com
[2] gilead.com

Top Domains in Tweet in G6:
[12] asco.org
[2] twitter.com
[1] cornell.edu
[1] cancer.gov
[1] peerview.com
[1] nejm.org

Top Domains in Tweet in G7:
[25] asco.org
[14] mdedge.com
[7] twitter.com
[6] flatiron.com
[5] unicancer.fr
[4] yalecancercenter.org
[2] gene.com
[2] comprehensivegenomicprofiling.com
[2] icl-lorraine.fr
[1] foundationmedicine.com

Top Domains in Tweet in G8:
[13] delveinsight.com
[11] healio.com
[7] linkedin.com
[6] cancerresearch.org
[6] calquencehcp.com
[3] asco.org
[3] ecancer.org
[2] tempus.com
[2] ac.uk
[2] iqvia.com

Top Domains in Tweet in G9:
[19] twitter.com
[16] asco.org
[13] linkedin.com
[8] saluteh24.com
[5] cancertherapyadvisor.com
[4] lecancer.fr
[3] co.jp
[3] medicalresearch.com
[2] ascopubs.org
[2] youtube.com

Top Hashtags
Top Hashtags in Tweet in Entire Graph:
[12779] asco20
[762] lcsm
[690] bcsm
[625] covid19
[505] oncoalert
[442] cancer
[325] ccc19
[318] breastcancer
[276] gerionc
[217] goasco20



Top Hashtags in Tweet in G1:
[4117] asco20
[554] lcsm
[298] oncoalert
[179] bcsm
[151] nsclc
[141] covid19
[140] crcsm
[111] lungcancer
[107] cancer
[106] breastcancer

Top Hashtags in Tweet in G2:
[3590] asco20
[413] bcsm
[241] covid19
[215] goasco20
[183] gyncsm
[173] listenupmbc
[125] cancer
[119] breastcancer
[87] ovariancancer
[86] asco2020

Top Hashtags in Tweet in G3:
[2992] asco20
[230] ccc19
[194] covid19
[150] covid19ncancer
[119] oncoalert
[117] prostatecancer
[96] lcsm
[94] gerionc
[83] bladdercancer
[80] cancer

Top Hashtags in Tweet in G4:
[199] asco20
[97] gerionc
[13] asco21
[11] rct
[9] geriatricassessment
[6] cipn
[6] oncoalert
[6] gap
[6] geriatricasssesment
[6] communityoncology

Top Hashtags in Tweet in G5:
[246] asco20
[20] multiplemyeloma
[18] cancer
[15] bitetechnology
[12] immunooncology
[12] nonmelanoma
[12] skincancer
[11] krasg12c
[8] squamouscellcarcinoma
[7] biomarkertesting

Top Hashtags in Tweet in G6:
[131] asco20
[20] prostatecancer
[12] covid19
[7] chemotherapy
[6] melanoma
[6] oncology
[5] rectalcancer
[4] research
[4] spartan
[4] prosper

Top Hashtags in Tweet in G7:
[172] asco20
[30] cancer
[16] asco2020
[12] unicancerasco20
[12] oncologypressroom
[12] oncoalert
[9] realworlddata
[9] prodige23
[8] headandneckcancer
[7] brca

Top Hashtags in Tweet in G8:
[107] asco20
[18] cancer
[15] bloodcancer
[13] oncology
[13] asco2020
[11] lungcancer
[10] immunotherapy
[10] asco
[8] clinicaltrials
[8] abstract

Top Hashtags in Tweet in G9:
[153] asco20
[9] oncology
[9] cancer
[6] asco2020
[6] asco
[5] breastcancer
[4] immunotherapy
[3] lungcancer
[3] covid19
[2] nsclc

Top Hashtags in Tweet in G10:
[99] cáncer
[99] msdlatam
[1] asco20

Top Words
Top Words in Tweet in Entire Graph:
[] Top Word Pairs in Tweet in Entire Graph
[] Entire Graph Count
[] Top Word Pairs in Tweet in G1

Top Words in Tweet in G1:
[6168] #asco20
[1371] #lcsm
[1364] patients
[926] #oncoalert
[917] trial
[906] oncoalert
[836] cancer
[825] asco
[812] vs
[788] pts

Top Words in Tweet in G2:
[5095] #asco20
[1106] asco
[934] cancer
[854] patients
[695] #bcsm
[483] dr
[455] oncoalert
[425] more
[370] #gyncsm
[363] w

Top Words in Tweet in G3:
[4924] #asco20
[1531] asco
[1044] cancer
[862] patients
[660] trial
[563] vs
[557] oncoalert
[472] data
[470] drchoueiri
[423] pts

Top Words in Tweet in G4:
[410] #asco20
[219] #gerionc
[150] cancer
[142] care
[135] rochgerionc
[128] older
[123] geriatric
[106] intervention
[103] assessment
[98] danengli

Top Words in Tweet in G5:
[369] #asco20
[101] more
[93] cancer
[92] virtual
[88] patients
[79] s
[76] asco
[67] amgen
[64] data
[53] year

Top Words in Tweet in G6:
[205] #asco20
[68] cancer
[58] patients
[47] therapy
[45] trial
[43] original
[43] article
[34] relugolix
[33] her2
[31] gastric

Top Words in Tweet in G7:
[203] #asco20
[64] patients
[55] #cancer
[47] asco
[40] data
[37] research
[36] more
[34] trial
[32] smilowcancer
[31] les

Top Words in Tweet in G8:
[181] #asco20
[69] cancer
[57] more
[48] learn
[46] patients
[46] re
[39] s
[27] study
[27] asco
[26] year

Top Words in Tweet in G9:
[154] #asco20
[22] cancer
[19] patients
[19] di
[16] data
[16] virtual
[15] more
[12] pazienti
[11] asco
[11] clinical

Top Words in Tweet in G10:
[198] más
[100] #asco20
[99] trabajamos
[99] prevenir
[99] #cáncer
[99] brindar
[99] pacientes
[99] opciones
[99] mejor
[99] calidad

Top Word Pairs
Top Word Pairs in Tweet in G2:
[648] #asco20,#bcsm
[269] asco,#asco20
[254] breast,cancer
[221] during,#asco20
[194] #bcsm,#asco20
[192] #asco20,oncoalert
[191] #asco20,asco
[188] #asco20,#gyncsm
[178] #listenupmbc,#asco20
[158] #bcsm,oncoalert

Top Word Pairs in Tweet in G3:
[316] asco,#asco20
[296] #asco20,asco
[156] covid,19
[130] psma,pet
[120] prostate,cancer
[118] #asco20,#covid19ncancer
[109] #asco20,#lcsm
[106] covid19nccc,#ccc19
[105] #asco20,#oncoalert
[91] high,risk

Top Word Pairs in Tweet in G4:
[493] #asco20,#gerionc
[274] geriatric,assessment
[216] older,adults
[197] assessment,driven
[151] rochgerionc,danengli
[133] driven,intervention
[127] improve,care
[126] care,older
[124] intervention,drug
[110] drug,fda

Top Word Pairs in Tweet in G5:
[118] learn,more
[101] year,s
[87] pro,tumor
[84] tumor,inflammation
[72] inflammation,pti
[70] #asco20,virtual
[70] novartis,boldly
[70] boldly,committed
[65] committed,reimagining
[65] reimagining,cancer

Top Word Pairs in Tweet in G6:
[46] original,article
[29] cancer,#asco20
[29] overall,survival
[29] prostate,cancer
[29] androgen,deprivation
[29] deprivation,therapy
[28] therapy,patients
[28] her2,positive
[28] trastuzumab,deruxtecan
[28] positive,gastric

Top Word Pairs in Tweet in G7:
[43] yalemed,ynhh
[35] smilowcancer,yalemed
[24] poster,presentation
[22] read,more
[21] excited,share
[21] share,findings
[19] findings,eaonc
[18] eaonc,trial
[17] trial,e3311
[17] e3311,today

Top Word Pairs in Tweet in G8:
[29] asco,#asco20
[28] #bloodcancer,#prostatecancer
[20] #prostatecancer,#lungcancer
[19] #lungcancer,#bladdercancer
[15] learn,janssen
[15] janssen,oncology
[15] oncology,re
[15] re,making
[15] making,news
[15] news,year

Top Word Pairs in Tweet in G9:
[17] rischio,di
[16] learn,more
[16] nei,pazienti
[16] nuovi,dati
[14] dati,per
[14] per,pazienti
[14] pazienti,ad
[14] ad,alto
[14] alto,rischio
[14] scientific,program

Top Word Pairs in Tweet in G10:
[7] trabajamos,prevenir
[6] prevenir,#cáncer
[6] #cáncer,brindar
[6] brindar,pacientes
[6] pacientes,más
[6] más,opciones
[6] opciones,mejor
[6] mejor,calidad
[6] calidad,vida
[5] vida,más

Top Replied-To
Top Replied-To in Entire Graph:
@marklewismd
@asco
@viveksubbiah
@tmprowell
@oncoalert
@narjustdumamd
@chadinabhan
@enriquesoto8
@renohemonc
@erikahamilton9

Top Replied-To in G1:
@marklewismd
@oncoalert
@angiedemichele
@mdmanishshah
@erikahamilton9
@tmprowell
@viveksubbiah
@narjustdumamd
@davidhongmd
@glopesmd

Top Replied-To in G2:
@tmprowell
@marklewismd
@oncoalert
@stage4kelly
@viveksubbiah
@coffeemommy
@asco
@erikahamilton9
@narjustdumamd
@chadinabhan

Top Replied-To in G3:
@asco
@renohemonc
@viveksubbiah
@marklewismd
@neerajaiims
@hemoncwarner
@enriquesoto8
@chadinabhan
@montypal
@paulobergerot

Top Replied-To in G4:
@danengli
@rochgerionc
@kmustian
@enriquesoto8
@srostoft
@drcbsteer
@vanitanoronha
@rzchipmd
@hemoncwarner
@drsukeshiarora

Top Replied-To in G5:
@emadshash

Top Replied-To in G6:
@thepcctc
@inespiresilva
@asco
@urotoday

Top Replied-To in G8:
@merck
@asco

Top Mentioned
Top Mentioned in Entire Graph:
@asco
@oncoalert
@drchoueiri
@davidfajgenbaum
@ascopres
@covid19nccc
@glopesmd
@erikahamilton9
@hemoncwarner
@tmprowell

Top Mentioned in G1:
@oncoalert
@asco
@weoncologists
@mdandersonnews
@egfrresisters
@erikahamilton9
@totalhealthconf
@ascopres
@n8pennell
@stephenvliu

Top Mentioned in G2:
@asco
@oncoalert
@davidfajgenbaum
@ascopres
@erikahamilton9
@hemoncwomendocs
@tmprowell
@drsgraff
@conquercancerfd
@burrisskip

Top Mentioned in G3:
@asco
@oncoalert
@drchoueiri
@covid19nccc
@glopesmd
@montypal
@hemoncwarner
@viveksubbiah
@tmprowell
@ascopres

Top Mentioned in G4:
@rochgerionc
@danengli
@williamdale_md
@asco
@khengsoo1
@mycarg
@ryannipp
@wilmotcancer
@siogorg
@cityofhope

Top Mentioned in G5:
@amgen
@asco
@sanofi
@tignum
@regeneron
@naturecancer
@embentay
@roche
@oncoalert
@scaltritilab

Top Mentioned in G6:
@nejm
@asco
@nyphospital
@gekehospers
@wcm_meyercancer
@oncoalert
@weillcornell
@shoreneal
@drscotttagawa
@cnsternberg

Top Mentioned in G7:
@asco
@smilowcancer
@yalemed
@ynhh
@groupeunicancer
@barbaraburtness
@foundationatcg
@upmchillmancc
@eaonc
@drnabilsaba

Top Mentioned in G8:
@asco
@merck
@icahnmountsinai
@mountsinainyc
@houstononcology
@qmbci
@conquercancerfd
@iqvia_global
@pfizer
@bostonchildrens

Top Tweeters
Top Tweeters in Entire Graph:
@hrblock_21
@threadreaderapp
@teshawnedmonds
@sddphoto
@onahunttoday
@pedrocantue
@gambiste1
@alizardx
@femtech_
@craybo23

Top Tweeters in G1:
@gideon_rose1224
@le_parisien
@nytimes
@pfanderson
@omi_082
@ebscbwi
@craigmatsuda
@gingin21
@ibrustyjim
@tomvarghesejr

Top Tweeters in G2:
@alizardx
@femtech_
@reuters
@cnbsnana
@michaelorndoff
@_takabo
@570karen
@natricer
@myglobalpac
@cnn

Top Tweeters in G3:
@threadreaderapp
@teshawnedmonds
@corruptnsw
@gma
@miamiherald
@drferdowsi
@evidencerobot
@_timos_
@elenpress
@mtmdphd

Top Tweeters in G4:
@psychdrd
@pd4ejp
@technojeder
@kathykastner
@gerisoc
@tildamc
@healthtypes
@patricklclary
@kilgore_cliff
@nicolestoutpt

Top Tweeters in G5:
@hrblock_21
@craybo23
@govsherazkhan
@nadiasindi
@beverlynotmypre
@rudyglove27
@heatherpeno
@dwatchnews
@hdpr2016
@vievararosel

Top Tweeters in G6:
@monitor_ph
@jaimedgeo
@bipinchauhan
@jinwonjung
@rosatiam
@pauloroberto_md
@jjcrazydiamond
@nbsharir
@prostateuk
@zerocancer

Top Tweeters in G7:
@rmr11rock
@ap
@hdawareness
@carolmariebensi
@turtleclub420
@aminekorchimd
@rkakamilan
@dennispowens1
@deptvetaffairs
@news_natural

Top Tweeters in G8:
@redboybroken
@wasregan
@f_camel
@northwind1ndn
@doc_tarry3
@bcharlote
@elizabe28958405
@stratcons
@soylarebelde
@5m23129

Top Tweeters in G9:
@salutedomani
@kj_hashi
@antoniocaperna
@biocentury
@bioworld
@dermanewsok
@buffaloden716
@aamdsif
@kbjones11
@saluteh24com

Top Tweeters in G10:
@pedrocantue
@idp240664
@salomnm
@rubenguzmanv85
@ricardocipago
@norarpa
@elisaelisa110
@hugoram47
@asdrubal1963
@gabrielalirax


We use necessary cookies to make our site work. We’d like to set additional cookies to understand site usage, make site improvements and to remember your settings. We also use cookies set by other sites to help deliver content from their services.